PulseMagic™ TrueForce™ PAF NMPA Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 150 participants.

Also called NCT07720557

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07720557
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07720557. Allocation not applicable; no masking; primary purpose treatment. Start 2026-07-10 (anticipated); primary completion 2028-07-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
PulseMagic™ TrueForce™ PAF NMPA Study
Acronym
PFATrueForce
Condition
Atrial Fibrillation (AF)
Condition
Paroxysmal AF
Condition
Drug Refractory Paroxysmal Atrial Fibrillation
Condition
Atrial Arrhythmia
Intervention (Device)
PFA Ablation catheter
Lead sponsor
Shanghai MicroPort EP MedTech Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct07720557
Content hash
a1e80ed2f808fa832fadb8fe36009027f3fbc4840578963a392025d3e870ca49